Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence-Reference-Cited by-同舟云学术

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence

Published:2017-07-21 Issue:10 Volume:30 Page:1387-1401
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ganci Federica,Sacconi Andrea,Manciocco Valentina,Covello Renato,Benevolo Maria,Rollo Francesca,Strano Sabrina,Valsoni Sara^ORCID,Bicciato Silvio^ORCID,Spriano Giuseppe,Muti Paola,Fontemaggi Giulia,Blandino Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201762.pdf

Reference38 articles.

1. Mitra S, Banerjee S, Misra C et al. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol 2007;60:1040–1047.

2. Leemans CR, Braakhuis BJ, Brakenhoff RH . The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9–22.

3. Ganci F, Sacconi A, Manciocco V et al, Radioresistance in head and neck squamous cell carcinoma: possible molecular markers for local recurrence and new putative therapeutic strategies. In: Marcu LG (ed.). Contemporary Issues in Head and Neck Cancer Management, 2015, pp 3–34.

4. Farah CS, John K, Wu J . Contemporary assessment and management of head and neck cancer surgical margins. In: Marcu LG (ed.). Contemporary Issues in Head and Neck Cancer Management, 2015, pp 75–130.

5. Braakhuis BJ, Bloemena E, Leemans CR et al. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. Oral Oncol 2010;46:485–491.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer;Biomarker Research;2024-03-05

2. MicroRNA expression profiling for disease progression assessment;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

3. Development of microRNA as prognostic markers in head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

4. Genome-wide discovery and prediction of microRNA-based biomarkers in head and neck squamous cell carcinoma;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

5. Role of microRNAs in metastasis, recurrence, and chemoradiation resistance of head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024